Drug Information

Drug General Information
Drug ID
D08OXU
Former ID
DCL001196
Drug Name
IMO-3100
Indication Autoimmune diabetes [ICD10:E08-E13] Phase 1 [550998]
Company
Idera Pharmaceuticals
Target and Pathway
Target(s) Toll-like receptor 9 Target Info Modulator
Toll-like receptor 7 Target Info Modulator
KEGG Pathway Toll-like receptor signaling pathway
Chagas disease (American trypanosomiasis)
African trypanosomiasis
Malaria
Tuberculosis
Measles
Herpes simplex infectionhsa04620:Toll-like receptor signaling pathway
Influenza A
NetPath Pathway BCR Signaling PathwayNetPath_11:TCR Signaling Pathway
PANTHER Pathway Toll receptor signaling pathwayP00054:Toll receptor signaling pathway
Reactome PI3K Cascade
Trafficking and processing of endosomal TLR
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
MyD88 dependent cascade initiated on endosomeR-HSA-1679131:Trafficking and processing of endosomal TLR
MyD88 dependent cascade initiated on endosome
WikiPathways Toll-like receptor signaling pathway
Toll-Like Receptors Cascades
MyD88 dependent cascade initiated on endosome
Trafficking and processing of endosomal TLR
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
Regulation of toll-like receptor signaling pathwayWP75:Toll-like receptor signaling pathway
Regulation of toll-like receptor signaling pathway
References
Ref 550998Clinical pipeline report, company report or official report of Idera Pharmaceuticals (2011).